We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Bone Cement May Prevent Amputations Due to Osteomyelitis

By HospiMedica International staff writers
Posted on 17 Feb 2009
Old technologies, bone cement, and a well known antibiotic may effectively fight osteomyelitis (OM) resulting from multi-drug-resistant (MDR) Acinetobacter baumannii infections in combat soldiers with compound bone fractures, claims a new study.

Researchers at the University of Rochester Medical Center (URMC; New York, NY, USA) generated a group of mice infected with MDR A. More...
baumannii strains isolated directly from soldiers wounded in Iran and Afghanistan. The mice were then treated with either colistin by injection, local colistin via Plexiglass (Polymethyl methacrylate, PMMA) bead bone cement, or a bone cement control with no drug. The researchers measured the amount of bacteria in the mice as they responded to treatment with a new test of parC gene activity--a gene known to be present only in A. baumannii. The researchers then confirmed that all study mice were infected with the bacteria, and that 75% of the strains were resistant to multiple antibiotics. The researchers found that the bone cement containing colistin significantly reduced the infection rate, so that only 29.2% of mice had detectable levels of parC after 19 days. Importantly, Colistin via injection failed to control the infection and was no better than placebo.

The researchers also took the first close look at the effect of A. baumannii and Staphylococcus aureus OM on bone biochemistry. When bacteria infect bone, they uncouple delicately balanced biochemical signaling responsible for the recycling of bone to preserve its strength, typically resulting in bone loss (osteolysis) that can be seen as a hole on X-rays. The researchers found, surprisingly, that in contrast to S. aureus OM, which is osteolytic and characterized by biofilm in necrotic bone, A. baumannii OM results in blastic (bone forming) lesions that do not contain apparent biofilm.

"Perhaps 2,000 soldiers come into field hospitals with compound fractures each year that become infected with A. baumannii,” said lead author Edward Schwarz, Ph.D., a professor of orthopedics in the center for musculoskeletal research at URMC. "About a third of them go on to get a staph infection after they reach the hospital, with about a third of those, perhaps 200 soldiers, suffering infectious complications that could cost them a limb. Studies already underway in our lab seek to clarify how the initial infections could gradually be replaced by catastrophic MRSA, and to prove that we can save limbs by putting an established antibiotic into bone cement for the first time.”

Osteomyelitis is a bone infection caused by various bacteria, and usually occurs in severe fractures when bone is exposed to open air. Although A. baumannii rarely causes OM in the United States, it is very prevalent in the Middle East, and is now present in more than 30% of soldiers recovering from open fractures in field hospitals in Iraq and Afghanistan. Outbreaks of the infection started among American soldiers returning from Iraq in 2003. At the same time, data began to emerge from hospitals treating soldiers suggesting that easily contracted A. baumannii may be arriving first at the fracture site and "priming” it so that it becomes more vulnerable to methicillin-resistant S. aureus (MRSA), which recently surpassed HIV as the most deadly pathogen in the United States, despite nearly universal use of the best available antibiotics.

Related Links:

University of Rochester Medical Center




Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Medical Adhesive
MED 5570U
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The method uses data streams commonly available on consumer wearables, including heart rate, physical activity, and oxygen saturation (photo courtesy of 123RF)
Image: The method uses data streams commonly available on consumer wearables, including heart rate, physical activity, and oxygen saturation (photo courtesy of 123RF)

Wearable AI Tool Predicts Hospitalization Risk in Heart Failure

Heart failure, a condition in which the heart cannot pump enough blood to meet the body’s needs, is a leading driver of unplanned hospital use. Clinicians often lack continuous insight into symptom changes... Read more

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.